FR2359135A1 - Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique - Google Patents

Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique

Info

Publication number
FR2359135A1
FR2359135A1 FR7720380A FR7720380A FR2359135A1 FR 2359135 A1 FR2359135 A1 FR 2359135A1 FR 7720380 A FR7720380 A FR 7720380A FR 7720380 A FR7720380 A FR 7720380A FR 2359135 A1 FR2359135 A1 FR 2359135A1
Authority
FR
France
Prior art keywords
phenoxy
lower alkyl
substd
propanolamine
cardio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7720380A
Other languages
English (en)
French (fr)
Inventor
Jean-Marie Teulon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexachimie SA
Original Assignee
Hexachimie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexachimie SA filed Critical Hexachimie SA
Publication of FR2359135A1 publication Critical patent/FR2359135A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7720380A 1976-07-22 1977-07-01 Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique Withdrawn FR2359135A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3064776 1976-07-22
GB5357676 1976-12-22

Publications (1)

Publication Number Publication Date
FR2359135A1 true FR2359135A1 (fr) 1978-02-17

Family

ID=26260544

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720380A Withdrawn FR2359135A1 (fr) 1976-07-22 1977-07-01 Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique

Country Status (11)

Country Link
JP (1) JPS5312851A (sv)
AU (1) AU2714177A (sv)
DE (1) DE2733305A1 (sv)
DK (1) DK329577A (sv)
ES (1) ES460866A1 (sv)
FR (1) FR2359135A1 (sv)
GR (1) GR61995B (sv)
NL (1) NL7707949A (sv)
NO (1) NO772604L (sv)
PT (1) PT66781B (sv)
SE (1) SE7708368L (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58160154U (ja) * 1983-03-01 1983-10-25 セイコーエプソン株式会社 印字装置
GB0319069D0 (en) * 2003-08-14 2003-09-17 Glaxo Group Ltd Therapeutically useful compounds
EP1737809B1 (en) 2004-02-27 2013-09-18 Amgen, Inc Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
US7465804B2 (en) 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
WO2007033002A1 (en) 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
WO2008030520A1 (en) 2006-09-07 2008-03-13 Amgen Inc. Heterocyclic gpr40 modulators
US7687526B2 (en) 2006-09-07 2010-03-30 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
US7572934B2 (en) 2007-04-16 2009-08-11 Amgen Inc. Substituted biphenyl GPR40 modulators
WO2009048527A1 (en) 2007-10-10 2009-04-16 Amgen Inc. Substituted biphenyl gpr40 modulators
JP2011515341A (ja) 2008-03-06 2011-05-19 アムジエン・インコーポレーテツド 代謝障害の治療に有用な立体配座的に制限されたカルボン酸誘導体
AU2009303475B2 (en) 2008-10-15 2012-09-13 Amgen Inc. Spirocyclic GPR40 modulators

Also Published As

Publication number Publication date
NO772604L (no) 1978-01-24
GR61995B (en) 1979-02-14
JPS5312851A (en) 1978-02-04
SE7708368L (sv) 1978-01-23
NL7707949A (nl) 1978-01-24
PT66781B (fr) 1978-12-18
DE2733305A1 (de) 1978-01-26
ES460866A1 (es) 1978-08-16
DK329577A (da) 1978-01-23
AU2714177A (en) 1979-01-25
PT66781A (fr) 1977-08-01

Similar Documents

Publication Publication Date Title
FR2359135A1 (fr) Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique
AR241528A1 (es) Un procedimiento para la preparacion de n-(3- o 4-((alquilamino)alquil)-fenil)alcansulfonamidas y sus sales.
FI935675A0 (fi) Pyrazolopyrimidiner
NO843836L (no) Terapeutisk aktive sulfamatderivater
FI860285A (fi) 6-tioxantinderivat.
NO304787B1 (no) Substituerte 1-okso-1,2-dihydro-isochinolinoyl- og 1,1-diokso-2H-1,2-benzotiazinoylguanidiner og anvendelse av forbindelsene for fremstilling av medikamenter
CA2003172A1 (en) Certain 2-(2',3',4'-trisubstituted benzoyl)-1,3-cyclohexanediones
MC1819A1 (fr) Composes 4-benzyl-piperazinyl substitues
DK324886D0 (da) Forgrenede polycarbonater indeholdende 2,4,6-tris(4'-hydroxyaryl)-amino-s-triaziner
CA1271199C (sv)
IT8419329A0 (it) Pomata oleosa avente un'eccellente attivita' anti-infiammatoria.
DK189988A (da) Pyridylalkansyreforbindelser med aktivitet som thromboxan a2-antagonister
FR2362115A1 (fr) Nouveaux aryloxy-1 amino-3 propanols-2, leur preparation et leur utilisation, notamment en therapeutique
DK248484D0 (da) Isoquinolinderivater
MC1281A1 (fr) Agents diuretiques
FR2181527A1 (en) 3-Phenoxy-1,2,5-thiadiazoles - with fungicidal activity
ES8500885A1 (es) Procedimiento para la preparacion de n-metil-n-bis-(3,4-dimetoxi-fenil-etil)-amina
SE8202351L (sv) Farmaceutiskt preparat
SU565494A1 (ru) ω-орто-хлоранилид α-изобутил-β-метилглутаровой кислоты или его натриевая соль, проявляющие противовоспалительную и анальгезирующую активность
SU613592A1 (ru) АЛКИЛОВЫЕ ЭФИРЫ ЦИКЛОГЕКСИЛ-β, β-ДИМЕТОКСИЭТИЛФОСФИНОВОЙ КИСЛОТЫ, ПРОЯВЛЯЮЩИЕ АНТИВИРУСНУЮ АКТИВНОСТЬ
FR2085633A1 (en) Anti-inflammatory 3-dialkyl aminoalkoxy-1h-indazoles
ES414785A1 (es) Procedimiento para la obtencion de composiciones fungicidasbasadas en anilidas de acidos 3-aminopropionicos.
FR2121447A2 (en) Beta-adrenergic blocking aryloxy-prop - anolamines
FR2357549A1 (fr) Triazoles substitues, leur preparation et leurs utilisations therapeutiques
SU1181283A1 (ru) ДИГИДРОХЛОРИДЫ 2-ФЕНИЛ-4-β-ДИАЛКИЛАМИНОЭТИЛПИРАЗОЛО/1,5-а/БЕНЗИМИДАЗОЛОВ, ОБЛАДАЮЩИЕ АНТИАРИТМИЧЕСКОЙ И ГИПОТЕНЗИВНОЙ АКТИВНОСТЬЮ

Legal Events

Date Code Title Description
RE Withdrawal of published application